PATENT CLAIM ANALYSIS

Application Number: 15955628
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["514", "043000"]

Abstract:
The present invention relates to therapies and therapeutic agents for use in the treatment of cardiomyopathies. In particular, the invention is concerned with, but not limited to therapies and therapeutic agents for use in the treatment of hypertrophic cardiomyopathy. Such therapeutic agents comprise hypomethylating agents.

Claim (Index 18):
The method of  claim 17 , wherein the cardiomyopathy is ischemic or non-ischemic cardiomyopathy.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 91.0
- Lexical Diversity: 1.6129
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12285380', '13554946', '14440567', '11187160', '14384955']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7406296888410033
- 35 USC 102 Novelty (BERT): 0.5073090868597157
- Combined Prediction Score: 0.7172976286428745
- Mean Citation Score: 235.925608
- Max Citation Score: 244.34843
- Similarity Product: 177.16252130065322

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test